Trial Profile
PRAsugrel versus TICagrelor for platelet inhibition in patients with non-ST segment elevation acute coronary syndrome (PRATIC).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2014
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms PRATIC
- 10 Mar 2014 New trial record